Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 21, 2010


Med BioGene has named Scott Davis to replace David Matthews as chief financial officer. Davis is a partner of Cross Davis & Company, an accounting and management contract services company.

Epigenomics' Chief Financial Officer Oliver Schacht plans to leave the company in March 2011. The company said that it has reached an agreement to hire an "experienced" CFO, whose name the firm will release in January due to confidentiality obligations, to take over the post in April. The company also plans to recruit a new US-based marketing and sales executive to lead its US operations, which are currently run by Schacht.

HistoRx has appointed Jack Davis to serve on its board of directors. Davis is the former President and CEO of Dianon Systems, which was bought by Laboratory Corporation of America in 2002. He also has served as CEO of Calypte Biomedical and worldwide general manager of Abbott Laboratories' Diagnostics Products business.

Rosetta Genomics said this week that Brian Markison has become an observer to the company's board of directors and, upon shareholder approval, will become a director. Markison is chairman and CEO of King Pharmaceuticals and led the company through to its recently announced acquisition by Pfizer. Before that, he was with Bristol-Myers Squibb.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.